In early December, the two companies signed an Agent Contract for Kilian presses for pharmaceutical and other applications in France that allows MEDELPHARM to sell Kilian production machines exclusively in France.

The agreement means MEDELPHARM can now add the highly respected Kilian Synthesis line, S250 Smart, and other rotary tablet presses to its range of high-speed quality laboratory tablet presses.

The latest agreement reinforces the existing partnership for Kilian’s distribution of MEDELPHARM’s own R&D presses world-wide, which has been in place since 2010.

Régis Cazes, Sales Director France at Medelpharm comments the partnership with Kilian Tableting as a natural extension of the existing synergetic cooperation.

"We are proud to represent Kilian Tableting on the French market. Kilian is an inevitable player in the global field of tablet presses and complements perfectly Medelpharm’s renowned expertise in solid dosage in the pharmaceutical and food market. The sales perspectives are extremely promising."

Links with Romaco

The agreement is a consequence of Germany’s Romaco group’s acquisition of Killian Tablet Press business, a 13-year-old stake previously owned by the Italian-based IMA Group.

Commenting on the purchase, Paulo Alexandre, CEO of the Romaco Group, declared: "Kilian possesses leading-edge tablet press technology and a strong worldwide reputation in a key area of pharma and food processing. Pharma and food markets are showing stable growth with faster expansion in emerging countries. The acquisition of Kilian will amplify Romaco Group’s equipment and service portfolio considerably and ideally supports our growth strategy."